Amarillo Biosciences, Inc. (OTCMKTS:AMAR – Get Free Report)’s share price traded down 14.3% on Monday . The stock traded as low as $0.60 and last traded at $0.60. 6,100 shares changed hands during mid-day trading, a decline of 67% from the average session volume of 18,253 shares. The stock had previously closed at $0.70.
Amarillo Biosciences Stock Down 14.3 %
The stock has a 50 day simple moving average of $0.60.
About Amarillo Biosciences
Amarillo Biosciences, Inc, a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases.
Featured Stories
- Five stocks we like better than Amarillo Biosciences
- What is the Euro STOXX 50 Index?
- The Average 401k Balance by Age Explained
- How to Read Stock Charts for Beginners
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- What is the S&P 500 and How It is Distinct from Other Indexes
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Amarillo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amarillo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.